Home › Trial NCT01830101
A Phase III Study of Re-Irradiation in Recurrent Glioblastoma
- Trial IDNCT01830101
- StatusWithdrawn
- PhasePhase 3
- Study typeInterventional
- SponsorAHS Cancer Control Alberta
- Enrollment—
- Start date2014-02
- ConditionsRecurrent Glioblastoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.